CoChat

NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosis

Open access
Malhotra, Sunny, Río, Jordi, Urcelay, Elena, Nurtdinov, Ramil, Bustamante, Marta F, Fernández, Oscar, Oliver, Begoña, Zettl, Uwe, Brassat, David, Killestein, Joep, Lechner-Scott, Jeannette, Drulovic, Jelena, Chan, Andrew, Martinelli-Boneschi, Filippo, García-Merino, Antonio, Montalban, Xavier, Comabella, Manuel · 2015 · Brain
Cited by 111

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Evidence exists for a potential modulation of inflammasome activity by interferon beta. Here, we investigated the roles of inflammasomes [absent in melanoma 2 (AIM2); NLR family, CARD domain containing 4 (NLRC4); NLR family, pyrin domain containing 1 and 3 (NLRP1 and NLRP3)] and related cytokines (IL1B, IL10, IL18) in the response to interferon beta in patients with relapsing-remitting multiple sclerosis. Ninety-seven patients treated with interferon beta were classified into responders and non-responders according to clinical criteria after 24 months and clinical-radiological criteria after 12 months of treatment. Messenger RNA expression levels of inflammasomes and cytokines were determined by real-time polymerase chain reaction in peripheral blood mononuclear cells collected before treatment with interferon beta. In a subgroup of patients, NLRP3 and IL1B expression was also determined after 3 months (n = 32) and 12 months (n = 20) of interferon beta treatment. A polymorphism located in the NLRP3 gene, rs35829419, was genotyped in 789 multiple sclerosis patients treated with interferon beta. Baseline mRNA expression levels for NLRP3 and IL1B were increased in peripheral blood mononuclear cells from non-responders compared to responders classified according to clinical criteria after 24 months (P = 0.02 and P = 0.001, respectively). No significant differences were observed for other inflammasomes and related cytokines. Differences in NLRP3 and IL1B expression remained significant following a clinical-radiological classification after 12 months (P = 0.007 and P = 0.02, respectively). After treatment with interferon beta, NLRP3 and IL1B expression was increased in responders but unchanged in non-responders. A trend for association was observed between rs35829419 and interferon beta response (pM-H = 0.08). These results point to a role of the NLRP3 inflammasome and its related cytokine IL1B in the response to interferon beta in patients with relapsing-remitting multiple sclerosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awu388

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 111

Metadata

Authors
Malhotra, S., Río, J., Urcelay, E., Nurtdinov, R., Bustamante, M. F., Fernández, O., Oliver, B., Zettl, U., Brassat, D., Killestein, J., Lechner-Scott, J., Drulovic, J., Chan, A., Martinelli-Boneschi, F., García-Merino, A., Montalban, X., & Comabella, M.
Venue
Brain
Published
2015-01-12
Volume
138
Issue
3
Pages
644-652
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2026694335
Cited by
111
References
4
FWCI
9.18
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosis. https://app.cochat.ai/papers/10.1093/brain/awu388
The paper
Malhotra, S., Río, J., Urcelay, E., Nurtdinov, R., Bustamante, M. F., Fernández, O., Oliver, B., Zettl, U., Brassat, D., Killestein, J., Lechner-Scott, J., Drulovic, J., Chan, A., Martinelli-Boneschi, F., García-Merino, A., Montalban, X., & Comabella, M. (2015). NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosis. Brain. https://doi.org/10.1093/brain/awu388

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.